Search Results - "Ruíz, Antonio Carlos Sánchez"

Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy by Urruticoechea, Ander, Rizwanullah, Mohammed, Im, Seock-Ah, Ruiz, Antonio Carlos Sánchez, Láng, István, Tomasello, Gianluca, Douthwaite, Hannah, Badovinac Crnjevic, Tanja, Heeson, Sarah, Eng-Wong, Jennifer, Muñoz, Montserrat

“…Purpose To assess the efficacy and safety of trastuzumab plus capecitabine with or without pertuzumab in patients with human epidermal growth factor receptor…”
Get full text

Peritoneal washing is an adequate source for somatic BRCA1/2 mutation testing in ovarian malignancies by Barquín, Miguel, Maximiano, Constanza, Pérez-Barrios, Clara, Sanchez-Herrero, Estela, Soriano, María, Colmena, Marta, García-Espantaleón, Manuel, Tejerina González, Eva, Gutierrez, Lourdes, Sánchez Ruiz, Antonio Carlos, Torrente, María, Provencio, Mariano, Romero, Atocha

“…•Peritoneal liquid cfDNA is a surrogate biomarker for ovarian tumour burden.•This novel approach improves treatment selection in BRCA mutation-associated…”
Get full text

Ocular relapse of primary brain lymphoma in immunocompetent patient, treated with intrathecal rituximab by Alonso, Constanza Maximiano, Sánchez Ruiz, Antonio Carlos, Sánchez de Ibargüen, Blanca Cantos, García, Miriam Méndez, Ronco, Isabel S., Pulla, Mariano Provencio

“…Primary brain lymphoma is a rare variant of extranodal non-Hodgkin’s B-cell lymphoma. In >90% of cases, this is diffuse large B-cell lymphoma with CD20…”
Get full text

Final overall survival (OS) analysis of PHEREXA: A randomized phase III trial of trastuzumab (H) + capecitabine (X) ± pertuzumab (P) in patients with HER2-positive metastatic breast cancer (MBC) who experienced disease progression during or after H-based therapy by Urruticoechea, Ander, Rizwanullah, Mohammed, Im, Seock-Ah, Sánchez Ruiz, Antonio Carlos, Lang, Istvan, Tomasello, Gianluca, Douthwaite, Hannah, Badovinac Crnjevic, Tanja, Heeson, Sarah, Eng-Wong, Jennifer, Munoz, Montserrat

“…Abstract only…”
Get full text

RAS analysis of circulating tumor cells from advanced colorectal cancer using BEAMing technology by Cabezas-Camarero, Santiago, García-Barberán, Vanesa, De la Orden-García, Virginia, Mediero-Valeros, Beatriz, Paz Cabezas, Mateo, López-Alfonso, Ana, Sánchez Ruiz, Antonio Carlos, Ruiz-Casado, Ana, Díaz-Millán, Isabel, Sastre, Javier, Sotelo Lezama, Miguel, Diaz-Rubio, Eduardo

“…Abstract only e15151 Background: RAS mutations predict a lack of response to anti-EGFR therapies in metastatic colorectal cancer (mCRC). BEAMing technology is…”
Get full text

Performance of two immunoafinity-based methods for CTC detection and molecular characterization in advanced colorectal cancer by Cabezas-Camarero, Santiago, De la Orden-García, Virginia, Veganzones-de-Castro, Silvia, Mediero-Valeros, Beatriz, Fuentes-Ferrer, Manuel Enrique, Sánchez Ruiz, Antonio Carlos, Provencio, Mariano, Aranda, Enrique, Sastre Valera, Javier, Diaz-Rubio, Eduardo

“…Abstract only…”
Get full text

High-dose Chemotherapy Followed by Autologous and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Follicular Non-Hodgkin's Lymphoma in the Rituximab Era by Escobar, Ignacio García, de Ibargüen, Blanca Cantos Sánchez, de Juan, Virginia Calvo, Alonso, C. Maximiano, García, Miriam Méndez, Ruíz, Antonio Carlos Sánchez, Pulla, Mariano Provencio

“…High-dose chemotherapy in lymphomas, and mainly non-Hodgkin's lymphomas, has been advancing since the 1970s. This therapeutic strategy is based on the supposed…”
Get full text

Cardio-respiratory fitness and functional performance in patients with a recent diagnosis of colorectal cancer by Alvarez-Bustos, Alejandro, Gutierrez Sanz, Lourdes Gutierrez, Nuñez García, Beatriz, Soriano, Maria, Fiuza-Luces, Carmen, Ramos, Javier, Sen, Jorge D., Sánchez-Ruiz, Antonio Carlos, Gomez-Bravo, Raquel, De La Puente, Blanca, Lucia, Alejandro, Ruiz-Casado, Ana

“…Abstract only 804 Background: Physical capability describes the ability to do the physical tasks of everyday living. Oncologists usually evaluate physical…”
Get full text

Clinical outcomes of FOLFIRINOX and gemcitabine/nab-paclitaxel in the real world setting by Franco, Fernando Franco, Juan C, Camara, Martin Valades, Jose Ignacio, Marrupe, David, Gutierrez Abad, David, Leon, Ana, Juez, Ignacio, De Torres, Maria Victoria, Sánchez-Ruiz, Antonio Carlos, Bernal, Elsa, Garcia Adrian, Silvia, Moreno, Diana, Cardena, Ana, Hernández, Roberto, Ruiz-Casado, Ana

“…Abstract only 440 Background: The incidence of pancreatic cancer is increasing in developed countries. Though FOLFIRINOX (FFX) and gemcitabine plus…”
Get full text

PHEREXA: A phase III study of trastuzumab (H) + capecitabine (X) ± pertuzumab (P) for patients (pts) who progressed during/after one line of H-based therapy in the HER2-positive metastatic breast cancer (MBC) setting by Urruticoechea, Ander, Rizwanullah, Mohammed, Im, Seock-Ah, Sánchez-Ruiz, Antonio Carlos, Lang, Istvan, Tomasello, Gianluca, Douthwaite, Hannah, Badovinac Crnjevic, Tanja, Heeson, Sarah, Eng-Wong, Jennifer, Munoz, Montserrat

“…Abstract only…”
Get full text